Page last updated: 2024-12-06

di-halo

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

di-halo: swimming pool disinfectant associated with contact dermatitis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID61828
CHEMBL ID3187930
SCHEMBL ID22576
MeSH IDM0117707

Synonyms (45)

Synonym
AC-20540
16079-88-2
c5h6brcln2o2
n-bromo-n'-chloro-5,5-dimethylhydantoin
di-halo
halogene t 30
caswell no. 114a
2,4-imidazolidinedione, 1-bromo-3-chloro-5,5-dimethyl-
agribrom
1-bromo-3-chloro-5,5-dimethylimidazolidine-2,4-dione
epa pesticide chemical code 006315
1-bromo-3-chloro-5,5-dimethyl-2,4-imidazolidinedione
einecs 240-230-0
1-bromo-3-chloro-5,5-dimethylhydantoin
slimicide 78p
slimicide c 77p
hydantoin, 1-bromo-3-chloro-5,5-dimethyl-
1-bromo-3-chloro-5,5-dimethyl hydantoin
A810184
bromochloro-5,5-dimethylhydantoin
hsdb 7489
w18o2g87nd ,
unii-w18o2g87nd
dtxcid1012591
tox21_302375
cas-16079-88-2
dtxsid3032591 ,
NCGC00255287-01
FT-0607481
AKOS015907949
bromo-3-chloro-5,5-dimethylhydantoin
bromo-3-chloro-5,5-dimethyl-2,4-imidazolidinedione, 1-
hydantoin, 1-bromo-3-chloro-5,5-dimethyl- [hsdb]
SCHEMBL22576
mfcd00037350
1-bromo-3-chloro-5,5-dimethylhydantoin, 95%
W-107975
DS-2481
W-110823
CHEMBL3187930
CS-0119915
Q27292179
dr. bromine
bromine sanitizer
SY104159

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The objective of this study was to investigate the toxic effect of BCDMH on zebrafish."( Study of the toxicity of 1-Bromo-3-chloro-5,5-dimethylhydantoin to zebrafish.
Chen, C; Huang, M; Jin, H; Li, C; Li, W; Liu, C; Wang, A; Wei, J; Zhang, J, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency70.97990.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency4.85580.006038.004119,952.5996AID1159521
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency31.23720.000627.21521,122.0200AID743202; AID743219
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (27.27)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's3 (27.27)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.59 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index69.38 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (18.18%)4.05%
Observational0 (0.00%)0.25%
Other9 (81.82%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]